Aim Interstitial lung disease (ILD) in infants represents a rare and heterogenous group of
disorders, distinct from those occurring in adults. In recent years a new entity within this …

在2020 年至2021 年新型冠状病毒肺炎(新冠肺炎) 疫情流行期间, 全球肺移植进入新发展阶段.
全球范围内, 上报国际心肺移植学会(ISHLT) 的肺移植数据已经超过70 000 例 …

Background Childhood interstitial lung disease (chILD) represents a rare heterogeneous
group of respiratory disorders. In the absence of randomized controlled clinical trials, global …

Die vorliegende 2019 S2k-Leitlinie der DGP wurde im Gegensatz zu den S3-Vorgänger-
Leitlinien aus dem Jahre 2004 und 2010 für Pneumologen verfasst, für Allgemeinärzte liegt …

For many decades, pediatric bronchoscopy has been an integral part of the diagnosis and
treatment of acute and chronic pulmonary diseases in children. Rapid technical advances …

Rationale: Variable disease course and outcomes have been reported in children's
interstitial lung disease associated with FLNA (Filamin A gene) variants. Objectives: To …

Genetic factors play an important role in chILD, and the ongoing development of novel
technologies will rapidly broaden the genetic landscape of chILD. Therefore, in the coming …

Summary chILD encompasses a collection of rare, diffuse lung diseases. Timely recognition
of children with suspected ILD and initiation of appropriate diagnostic evaluations will …

Childhood interstitial lung disease (chILD) is a large and heterogeneous group of disorders
characterized by diffuse lung parenchymal markings on chest imaging and clinical signs …

Population-based, longitudinal studies spanning decades linking risk factors in childhood,
adolescence and early adulthood to incident clinical interstitial lung disease (ILD) events in …